Study of mRNA Vaccine Formulation against COVID-19 in Healthy Adults 18 Years of Age and Older

Trial Identifier: VAW00001
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: March 2021
Primary Completion Date: June 2022
Study Completion Date: June 2022
Condition: COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Australia, Queensland Morayfield, Queensland, Australia, 4506
Australia, Queensland South Brisbane, Queensland, Australia, 4101
Australia, Victoria Melbourne, Victoria, Australia, 3010
Australia, Western Australia NEDLANDS, Western Australia, Australia, 6009
Brazil, Bahia Salvador, Bahia, Brazil, 40415-006
Brazil, Mato Grosso do Sul Campo Grande, Mato Grosso do Sul, Brazil, 79070-900
Brazil, Minas Gerais Belo Horizonte, Minas Gerais, Brazil, 30110-063
Honduras Barrio Del Centro, Honduras, 11101
Honduras San Pedro Sula, Honduras, 21104
United States, California Rolling Hills Estates, California, United States, 90274
United States, Florida Hollywood, Florida, United States, 33024
United States, Florida Miami, Florida, United States, 33135
United States, Iowa Iowa City, Iowa, United States, 52242
United States, Missouri Kansas City, Missouri, United States, 64114
United States, Nebraska Omaha, Nebraska, United States, 68134
United States, New York ROCHESTER, New York, United States, 14609
United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104
United States, South Carolina North Charleston, South Carolina, United States, 29405
United States, Tennessee Knoxville, Tennessee, United States, 37920
United States, Texas Houston, Texas, United States, 77081
United States, Utah Salt Lake City, Utah, United States, 84107